Blog

Amryt licenses gene therapy platform – Proactive Investors UK


Proactive Investors UK

Amryt licenses gene therapy platform
Proactive Investors UK
The technology has been licensed from University College Dublin and involves the delivery of gene therapy using high branched poly (β-amino ester) polymer technology. The initial focus of development efforts to date has been in the area of EB and

2018-03-15 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.